Pale Fire Capital SE’s Vera Therapeutics VERA Stock Holding History

Pale Fire Capital SE’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,389	Closed	-$252K	–	77
2023 Q4	$252K	Buy	+16,389	New	+$208K	0.04%	47

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pale Fire Capital SE's VERA Position: Q1 2024 in Review

Pale Fire Capital SE sold out of Vera Therapeutics (VERA) in Q1 2024, closing a stake of 16,389 shares — an estimated $252K sold.

Pale Fire Capital SE first reported a position in VERA in Q4 2023 and held it in 1 quarter. The position peaked at $252K in Q4 2023. 160 funds tracked by Wall St. Rank hold VERA as of Q1 2024.

Pale Fire Capital SE reported no remaining Vera Therapeutics position as of Q1 2024 after selling out during the quarter.
Pale Fire Capital SE sold 16,389 Vera Therapeutics shares in Q1 2024, an estimated $252K.
Pale Fire Capital SE first reported a position in Vera Therapeutics in Q4 2023 and held it in 1 quarter.
Pale Fire Capital SE's Vera Therapeutics position peaked at $252K in Q4 2023.
160 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2024.

Based on Pale Fire Capital SE's 13F filing for Q1 2024, filed 14 May 2024.